A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback